Table 1.
Control group (n = 16) | Bupivacaine group (n = 20) | p | ||
---|---|---|---|---|
Characteristic | Age (year) | 51.2 ± 13.5 | 53.1 ± 14.8 | 0.581 |
Male gender | 9 (56%) | 11 (55%) | 0.940 | |
| ||||
ASA status | II | 6 (38%) | 8 (40%) | 0.878 |
III | 10 (63%) | 12 (60%) | ||
| ||||
Preoperative comorbidities | Hypertension | 4 (25%) | 6 (30%) | 0.519 |
Diabetes mellitus | 4 (25%) | 7 (35%) | 0.391 | |
Asthma | 1 (6%) | 2 (10%) | 0.585 | |
Old cerebral embolism | 1 (6%) | 1 (5%) | 0.698 | |
Old myocardial infarction | 1 (6%) | 1 (5%) | 0.698 |
Continuous variables were described as mean ± standard deviation, and the categorical variable was described as number of events (n/%); the remaining parameters were compared using an independent t-test, and statistical significance was considered when p < 0.05. Categorical variables were the number of events (n); the Chi-square test was used, and events less than 5 were compared with Fisher's exact test, p < 0.05.